477 related articles for article (PubMed ID: 22458564)
21. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Marzano AV; Frezzolini A; Caproni M; Parodi A; Fanoni D; Quaglino P; Girgenti V; La Placa M; Fabbri P; Caputo R; Berti E
Int J Immunopathol Pharmacol; 2007; 20(3):557-66. PubMed ID: 17880768
[TBL] [Abstract][Full Text] [Related]
22. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
[TBL] [Abstract][Full Text] [Related]
23. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
Porebski G; Pecaric-Petkovic T; Groux-Keller M; Bosak M; Kawabata TT; Pichler WJ
Clin Exp Allergy; 2013 Sep; 43(9):1027-37. PubMed ID: 23957338
[TBL] [Abstract][Full Text] [Related]
24. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration.
Inachi S; Mizutani H; Shimizu M
Arch Dermatol; 1997 Jul; 133(7):845-9. PubMed ID: 9236522
[TBL] [Abstract][Full Text] [Related]
25. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell apoptosis in severe drug-induced bullous eruptions.
Verneuil L; Ratajczak P; Allabert C; Leboeuf C; Comoz F; Janin A; Ameisen JC
Br J Dermatol; 2009 Dec; 161(6):1371-5. PubMed ID: 19575754
[TBL] [Abstract][Full Text] [Related]
27. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
Murata J; Abe R; Shimizu H
J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
[TBL] [Abstract][Full Text] [Related]
28. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
Friedmann PS; Strickland I; Pirmohamed M; Park BK
Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
[TBL] [Abstract][Full Text] [Related]
29. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
Yager JA
Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
[TBL] [Abstract][Full Text] [Related]
30. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
31. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of histologic features of toxic epidermal necrolysis.
Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
[TBL] [Abstract][Full Text] [Related]
33. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
34. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
35. Animal models of toxic epidermal necrolysis.
Azukizawa H
J Dermatol; 2011 Mar; 38(3):255-60. PubMed ID: 21342227
[TBL] [Abstract][Full Text] [Related]
36. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.
Morel E; Alvarez L; Cabañas R; Fiandor A; Díaz R; Escamochero S; Prior N; Blanca M; Bellón T
Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148
[TBL] [Abstract][Full Text] [Related]
37. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Koh MJ; Tay YK
Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
[TBL] [Abstract][Full Text] [Related]
38. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
[TBL] [Abstract][Full Text] [Related]
39. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
[TBL] [Abstract][Full Text] [Related]
40. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Abe R
J Dermatol; 2015 Jan; 42(1):42-8. PubMed ID: 25355273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
